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Friend murine leukemia virus (Fr-MLV) clone A8 causes spongiform neurodegeneration in the rat brain. The A8-env gene is a primary
determinant of neuropathogenicity, and the 1.5-kb ClaI–HindIII fragment containing the LTR and 5V leader from A8 are additionally required
for spongiosis. After replacement of the A8 enhancer region of the neuropathogenic chimera with the enhancer region of non-
neuropathogenic 57, viral titer in the brain was reduced by two orders of magnitude. However, the A8 enhancer region was not responsible
for the induction of spongiosis. The region responsible for neuropathogenesis was located in the 0.3-kb KpnI–AatII fragment of A8
containing the R-U5-5V leader. The chimeric virus possessing this 0.3-kb fragment of A8 and the A8-env in the 57 background induced a high
rate of spongiform neurodegeneration within 7 weeks (9/9 of infected rats). Studies using cultured cells suggest that the 0.3-kb fragment
influences the expression of Env protein. Furthermore, these neuropathogenic chimerae, despite low viral replication in the brain, exhibited a
stronger expression of Env protein compared with that of non-neuropathogenic viruses.
D 2005 Elsevier Inc. All rights reserved.
Keywords: Spongiform neurodegeneration; Rat; Determinant; R-U5-5V leader sequence; Env protein; Retrovirus; Murine leukemia virus clone A8Introduction
A neuropathogenic variant of Friend murine leukemia
virus (Fr-MLV), FrC6 virus clone A8, induces spongiform
neurodegeneration without inflammatory infiltrates when
infected into neonatal rats (Takase-Yoden and Watanabe,
1997; Watanabe and Takase-Yoden, 1995). Studies with
chimerae constructed from A8 virus and non-neuropatho-
genic Fr-MLV clone 57 (Oliff et al., 1980) identified the env
gene of A8 as a primary determinant for the induction of
spongiform neurodegeneration in the brains of infected rats,
and the 1.5-kb ClaI–HindIII fragment containing the LTR
and 5V leader sequence of A8 as necessary for neuro-
pathogenicity (Takase-Yoden and Watanabe, 1997). Several
MLVs cause spongiform neurodegeneration when infected
into neonatal mice and/or rats (Bilello et al., 1986; Czub et0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: takase@t.soka.ac.jp (S. Takase-Yoden).al., 1995; Gardner, 1978; Kai and Furuta, 1984; Tanaka et
al., 1998; Wong, 1990; Wong et al., 1983). One common
feature of these viruses, including A8 virus, is that the
primary determinant for the induction of neurodegenerative
disease is the env gene. Other viral genes also have an effect
on neuropathogenicity. In the case of CasBrE, PVC211, and
PVC441, the sequences within the LTR, the 5V leader region,
and the gag-pol also affect neurovirulence (Czub et al.,
1992; DesGroseillers et al., 1985; Masuda et al., 1993;
Portis et al., 1991, 1994; Tanaka et al., 2000).
Some uninfected neurons may exhibit cytopathogenicity,
indicating an indirect mechanism of MLV-induced neuro-
pathogenicity (Portis, 2001; Wiley and Gardner, 1993).
However, the patho-mechanism of spongiosis induced by
env and other genes is still not understood. It has been
reported that microglial infection appears to be necessary for
the induction of spongiform neurodegeneration in the brains
of mice or rats infected with neuropathogenic viruses
(Baszler and Zachary, 1990, 1991; Czub et al., 1995; Gravel2005) 1–10
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been reported that the infection of brain capillary endothelial
cells correlates with neuropathogenicity in PVC211-infected
rats (Masuda et al., 1996). iNOS expression in the infected
cells may play an important role in neurodegeneration
(Jinno-Oue et al., 2003). Other cellular effectors involving
several lymphokines and cytokines have been found as
aberrantly expressed in the brain of infected animals, but it
is not clear whether these effectors are required for the
development of neurodegenerative lesions (Askovic et al.,
2001; Choe et al., 1998; Jolicoeur et al., 2003; Kim et al.,
2002; Nagra et al., 1994; Peterson et al., 2001; Zachary et
al., 1997). Recently, Dimcheff et al. (2003) reported that
endoplasmic reticulum (ER) stress responses induced by the
accumulation of uncleaved Env precursor protein correlate
with retrovirus-induced spongiform neurodegeneration in
FrCasE-infected mice.
In this study, we identified the minimal genetic determi-
nant within the LTR and 5V leader of A8 that controls
neuropathogenicity. Studies using chimerae of A8 and non-
neuropathogenic MLV clone 57 revealed that the 0.3-kb
KpnI–AatII fragment containing 0.04-kb of R, U5, and the
5V half of the 5V leader of A8 is essential for the induction of
spongiform neurodegeneration. Furthermore, we compared
the amount of viral DNA, viral transcripts, and viral protein
in the cultured cells infected with chimeric viruses, and
discussed the role of the 0.3-kb KpnI–AatII fragment of A8
in viral replication.Materials and methods
Viruses and cells
Neuropathogenic FrC6 virus clone A8 was obtained as
described previously (Takase-Yoden and Watanabe,
1997,Watanabe and Takase-Yoden, 1995). The infectious
DNA of clone 57 of Fr-MLV (Oliff et al., 1980) and A8 was
transfected into NIH3T3 cells, and a virus-producing cell
culture was established. The supernatants of these cells were
used to infect NIH3T3 cells, and virus-producing cultures
were used in the experiments. Virus titers were determined
by XC cell-plaque assay on C182 cells in the presence of 10
Ag/ml of Polybrene (Rowe et al., 1970). C182 cells were
grown on minimum essential medium supplemented with
10% calf serum. XC cells, NIH3T3 cells, and rat glial F10
cells (Sun et al., 1993; Wekerle et al., 1987) were grown on
Dulbecco’s modified Eagle’s medium containing 10% fetal
calf serum.
Construction of chimeric viruses
Chimeric viruses combining A8 and 57 were prepared as
follows: R7a was constructed by replacing the AatII–
HindIII fragment containing the 3V half of the 5V leader
sequence, gag and pol genes of A8 with the correspondingfragment of 57. The construction of R7c involved replacing
the BlpI–HphI fragment of A8-LTR of R7a with the BlpI–
BsiEI fragment of 57-LTR. Ligation of the HphI and BsiEI
sites was performed using an XhoI linker. The construction
of R7g involved replacing the KpnI–HindIII fragment
containing the 3V half of the R region and U5 of LTR, the
5V leader sequence, gag and pol genes of A8 with the
corresponding fragment of 57. R7e was constructed by
replacing the HindIII–HindIII fragment containing gag and
pol genes and the ClaI–KpnI fragment containing the 3V
terminus of the env gene, the intergenic region, the U3, and
the 5V half of the R region in the LTR of A8 with the
corresponding fragments of 57. R7f was constructed by
replacing the AatII–HindIII fragment and the ClaI–KpnI
fragment of A8 with the corresponding fragments of 57.
R7b was constructed by replacing the HindIII–HindIII
fragment containing gag and pol genes and the ClaI–AatII
fragment containing the 3V terminus of the env gene, the
intergenic region, LTR, and the 5V half of the 5V leader
sequence of A8 with the corresponding fragments of 57.
R5a was constructed by replacing the BlpI–BsiEI fragment
of 57-LTR of Rec5 with the BlpI–HphI fragment of A8-
LTR. The XhoI-linker was used to ligate the HphI and BsiEI
sites. Rec5 was constructed by replacing the SphI–ClaI
fragment containing the env gene of 57 with the corre-
sponding fragment of A8. The structures of chimeric viruses
were confirmed by digestion with restriction enzymes and
sequence analysis. Basic recombinant DNA procedures
were performed according to standard methods (Sambrook
et al., 1989).
Animal experiments
The ability of viruses to cause disease was assessed
using newborn Lewis rats purchased from a commercial
breeder. Newborn rats were inoculated intraperitoneally
with 0.1 ml and intracerebrally with 0.005 ml of viral
supernatant. The titers of the inoculated virus were A8: 9
rats, 2.8  105 XC-PFU/rat; 4 rats, 3.8  105 XC-PFU/
rat; 1 rat, 1.7  106 XC-PFU/rat. R7a: 6.4  104 XC-
PFU/rat. R7c: 8.4  104 XC-PFU/rat. R7g: 2.8  104
XC-PFU/rat. R7e: 1.5  104 XC-PFU/rat. R7f: 2.8  104
XC-PFU/rat. R7b: 4.4  104 XC-PFU/rat. R5a: 1.5 
104 XC-PFU/rat. Rec5: 1.0  104 XC-PFU/rat. 57: 3
rats, 1.8  104 XC-PFU/rat; 15 rats, 9.3  104 XC-PFU/
rat. Neurodegeneration in the CNS was determined at 5
w-pi: 3 rats; 6 w-pi: 5 rats; 7 w-pi; 2 rats; 8 w-pi: 3 rats;
10 w-pi: 1 rat (A8), 6 w-pi: 5 rats; 7-w-pi: 5 rats; 8 w-
pi: 2 rats; 9 w-pi: 1 rat; 10 w-pi: 2 rats (R7a), 7 w-pi: 3
rats; 8 w-pi: 7 rats (R7c), 7 w-pi: 3 rats; 8 w-pi: 9 rats
(R7g), 7 w-pi: 8 rats (R7e), 7 w-pi: 9 rats (R7f), 6 w-pi:
6 rats; 7 w-pi: 6 rats (R7b), 7 w-pi: 8 rats; 8 w-pi: 3 rats
(R5a), 8 w-pi: 4 rats; 9 w-pi: 6 rats (Rec5), and 6 w-pi:
1 rat; 8 w-pi: 9 rats; 9 w-pi: 8 rats (57).
After exsanguination of the infected animals, the brain
and spleen were homogenized in cold phosphate-buffered
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infectious virus titers were determined by the XC cell-
plaque assay (Rowe et al., 1970). For histological analysis,
the organs were immersed in 4% paraformaldehyde buffered
with 0.12 M phosphate (pH 7.3) and fixed. The tissues were
embedded in paraffin for histological staining with hema-
toxylin and eosin.
Histology
The degree of spongiform neurodegeneration was scored
as follows: 0, no lesions; 1, less than 20 vacuoles in the total
area; 2, 20 to 100 vacuoles counted in the field at 10
magnification (field (10)); 3, clusters consisting of over
100 vacuoles spread within one field (10); 4, clusters
consisting of over 100 vacuoles scattered over 2 fields
(10); 5, clusters of vacuoles occupying over 30% of the
total area. The scores were separately determined at the
cortex, thalamus, cerebellum, brain stem, and spinal cord.
The sum of each score in the five areas is shown in Table 1.
For detection of the viral antigen, goat anti-Rauscher
MLV gp70 (Quality Biotech Incorporated Resource Labo-
ratory) and paraffin sections were used. Non-specific
antibody binding was blocked by incubation of the sections
and the cells in 50% normal mixed serum (fetal calf, calf,
pig, and horse) diluted in PBS. Biotinylated rabbit anti-goat
IgG (ZYMED Laboratories Inc.) was used as a secondary
antibody followed by treatment with avidin–peroxidase
complex (ZYMED Laboratories Inc.). PBS washing was
performed between each step. After primary antibody
incubation, the non-specific activity of endogenous peroxi-
dase was blocked by incubation of the cells with 0.3% H2O2Table 1
Neuropathogenicity and titers of A8, 57, and their chimeric viruses
Virus Spongiosis Clinical disea
Incidence (%) Intensity of lesionc
A8 100 (14/14) 10.8 F 0.6 (14) 7/10
R7a 100 (15/15) 8.6 F 0.4 (15)e 2/15
R7c 100 (10/10) 6.4 F 0.5 (10) 0/10
R7g 8 (1/12) 1.0 (1)g 0/12
R7e 100 (8/8) 6.7 F 0.4 (8) 0/8
R7f 100 (9/9) 6.4 F 0.9 (9)i 0/9
R7b 25 (3/12) 2.3 F 0.9 (3)g 0/12
R5a 0 (11) 0.0 (11) 0/11
Rec5 0 (10) 0.0 (10) 0/10
57 0 (18) 0.0 (18) 0/18
a Number of rats expressing hind-leg paralysis or weakness.
b The virus titers were determined as described in Materials and methods. Values
numbers of rats.
c The intensity of lesions was determined as described in Materials and methods. M
rats.
d Details are described in Materials and methods.
e P b 0.01 vs. A8- and R7c-infected rats. P b 0.05 vs. R7f-infected rats, and P
f P b 0.001 vs. R7a-infected rats by t test.
g Rats with spongiosis.
h Difference is not significant compared to R7c-infected rats by the t test ( P N 0
i P b 0.001 vs. A8-infected rats by t test. Difference is not significant compared
j Difference is not significant compared to R7e- and R7b- infected rats by the tin methanol. For the peroxidase reaction, 0.2 mg/ml 3,3V-
diaminobenzidine tetrahydrochloride (DAB) (DOTIDE) in
0.1 M Tris buffer (pH 7.6) was used. The intensity of
antigen expression was scored either in blood vessels or in
glial cells of the central nervous system (CNS), in the
selected seven areas, cerebral cortex, thalamus, cerebellar
cortex, cerebellar white matter and dentate nucleus, pons,
grey matter and white matter of the spinal cord. The degree
of antigen expression in the blood vessels was scored as
follows: 0, no antigens; 1, less than 10% antigen-positive
blood vessels in the area; 2, 10–20% antigen-positive blood
vessels in the area; 3, 20–50% antigen-positive blood
vessels in the area; 4, more than 70% antigen-positive
blood vessels in the area. The degree of antigen expression
in the glial cells was scored as follows: 0, no antigens; 1, a
few antigen-positive glial cells in total area; 2, more than 10
antigen-positive glial cells in the field at 10 magnification
(field (10)); 3, more than three fields (10) containing
more than 10 antigen-positive glial cells; 4, fields with more
than 10 antigen-positive glial cells occupying more than
70% of the area. The sum of each score in the seven separate
areas is shown in Table 2.
Viral DNA analysis
Genomic DNAwas isolated from R7f-, Rec5-, and mock-
infected F10 cells at 4 days post-infection using QIAGEN
Genomic-tips (QIAGEN) according to the manufacturer’s
instructions. R7f and Rec5 were infected into F10 cells at
moi 0.1. For detection of total virus DNA, PCR was
performed with a 50-Al reaction mixture containing 0.2 mM
each of deoxyribonucleotides, 2 mM MgSO4, 300 nMsea Virus titer(log10XC-PFU/g)in
b Weeks
post-infection
Brain Spleen
5.1 F 0.2 (5) NT 5–10d
4.4 F 0.3 (6) 5.7 F 0.2 (4) 6–10d
2.6 F 0.2 (6)f 5.0 F 0.6 (4) 7–8
2.2 F 0.2 (4)h 5.4 F 0.3 (4) 7–8
3.3 F 0.0 (3) 5.7 F 0.1 (3) 7
3.1 F 0.2 (3)j 5.1 F 0.1 (3) 7
2.8 F 0.2 (5)h NT 6–7
2.3 F 0.2 (5)h 4.4 F 0.4 (5) 7–8
2.3 F 0.1 (4)h 4.8 F 0.3 (5) 8–9
2.5 F 0.0 (4)h NT 6–9
are mean log10XC-PFU/g F SE. The numbers in parentheses represent the
eans and SE are indicted. The numbers in parentheses represents number of
b 0.001 vs. R7b-infected rats by t test.
.1).
to R7c- and R7e-infected rats by the t test ( P N 0.5).
test ( P N 0.1).
Table 2
The level of expression of Env protein in cells of CNSa
Virus (Number of rats) Env-positive cells
Blood vessel Glial cell
A8(3) 18.5 F 0.5b 13.8 F 0.4b
R7f(3) 21.3 F 1.5c 10.5 F 0.9d
R7c(7) 23.4 F 0.5b,c 13.0 F 1.2b,c
Rec5(4) 3.0 F 1.4e 1.5 F 1.2e
57(3) 1.7 F 0.7 0.3 F 0.3
a The levels of antigen expression were scored as described in Materials
and methods. Means and SE are indicated.
b Difference is not significant compared to R7f-infected rats by the t test.
c P b 0.001 vs. Rec5-infected rats.
d P b 0.01 vs. Rec5-infected rats.
e Difference is not significant compared to 57-infected rats by the t test.
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CAGCTTTGATCGAGTCC-3V, anti-sense; 5V-CACATTG-
GTTTCTTGCCCTGG-3V), 600 nM primers for detection of
the rat h-globin gene (sense; 5V-GATACTGTTGTGTT-
GACTCGCA-3V, anti-sense; 5V-GGGAAACATAGCCAGA-
AGACAA-3V) as an internal control, 100 ng of template
DNA, and 1 unit of KOD-Plus- DNA polymerase
(TOYOBO, Co., LTD.) in PCR buffer for KOD -Plus- from
the supplier. Mineral oil was overlaid, and the cycling
conditions were as follows: denaturation at 94 8C for 2 min,
then 24 or 26 cycles of denaturation at 94 8C for 15 s,
annealing at 65 8C for 30 s, and extension at 68 8C for 30 s.
Aliquots of the PCR mixture were analyzed on a 3% agarose
gel, and visualized and quantified under ImageMaster VDS-
CL (Amersham Bioscience Corp., USA) after ethidium-
bromide staining.
Viral transcript analysis
Total RNA was isolated from R7f-, Rec5-, and mock-
infected F10 cells at 4 days post-infection using RNeasy
(QIAGEN) according to the manufacturer’s instructions. R7f
and Rec5 were infected into F10 cells at moi 0.1. The
extracted RNA was treated with DNaseI to remove contam-
inating DNA. First-strand cDNAwas synthesized from 5 Ag
of total RNA by a reaction with SuperScript First-Strand
Synthesis System for RT-PCR (Invitrogen) with a random
primer, in accordance with the manufacturer’s instructions.
Second-strand DNA corresponding to the spliced viral
transcripts was synthesized by PCR performed with a 50-Al
reaction mixture containing 0.2 mM each of deoxyribonu-
cleotides, 2 mM MgSO4, 600 nM each of a universal primer
(5V-TCTTTCATTTGGGGGCTCGT-3V) and a reverse primer
(5V-TCAGTAGGACGGTATAGGGT-3V), 1 unit of KOD
-Plus- DNA polymerase (TOYOBO, Co., LTD.), and the
template cDNA in PCR buffer for KOD-Plus- from the
supplier. Second-strand DNA corresponding to full-length
viral transcripts was synthesized by PCRwith 600 nM each of
a universal primer (5V-ACTTCCCTGATCCTGACATG-3V)
and a reverse primer (5V-TCAGTAGGACGGTATAGGGT-
3V). In order to perform relative quantitative RT-PCR,Quantum RNA 18S Internal Standards (Ambion, Inc. USA)
was used. Briefly, the primer set that amplified second-strand
DNA corresponding to 18S ribosomal RNAwas used in each
reaction as an internal standard, in accordance with the
manufacturer’s protocol. In each sample, PCRwas performed
at 21, 23, 25, 27, and 29 cycles, and the linear range was
determined. In all samples used in this experiment, the con-
dition of 25 cycles was included in the linear range. Cycling
conditions were as follows: denaturation at 94 8C for 2 min,
then 25 cycles of denaturation at 94 8C for 15 s, annealing at
60 8C for 30 s, extension at 68 8C for 1 min, and an additional
10 min at 68 8C. Aliquots of the PCR mixture were analyzed
on a 3% agarose gel, and visualized and quantified with
ImageMaster VDS-CL after ethidium bromide staining.
Immunoblot analysis
Western blot analysis was performed on R7f-, Rec5-, and
mock-infected F10 cells at 4 days post-infection. R7f and
Rec5 were infected into F10 cells at moi 0.1. A8-infected
F10 cells were used as a control. Cells were washed with
PBS and then lysed with 2% sodium dodecyl sulfate (SDS)
and 0.5 mM phenyl methyl sulfonyl fluoride (PMSF) in
PBS on 100 8C for 5 min. Nucleic acid was sheared using a
syringe with a 22-gauge needle. Sample buffer (5)
containing SDS, dithiothreitol (DTT), glycerol, and bromo-
phenol blue in Tris–HCl (pH 6.8) was added to the lysate.
After boiling for 5 min, the lysates were loaded on 15%
SDS-polyacrylamide gel. The proteins were then transferred
onto an Immobilon P membrane (Millipore) by electro-
blotting and probed with goat anti-Rauscher MLV gp70 and
anti-AKR p30Gag (Quality Biotech Incorporated Resource
Laboratory). Goat anti-actin (Santa Cruz Biotechnology,
Inc.) was used as a loading control. Horseradish peroxidase-
conjugated anti-goat IgG antibody (Santa Cruz Biotechnol-
ogy, Inc.) was used as a secondary antibody. The membrane
was developed with ECL Plus reagents (Amersham Bio-
sciences Corp., USA), and bands were visualized and
quantified with ImageMaster VDS-CL.Results
Env and other viral determinants of neuropathogenicity of
the A8 virus
To determine the sequences responsible for inducing
neurological disease within the 1.5-kb ClaI–HindIII frag-
ment of A8, containing the LTR and 5V leader sequence, we
constructed new chimerae between A8 and 57 and injected
them into newborn Lewis rats (Fig. 1). As shown in Table 1,
chimera Rec5, which contains the SphI–ClaI fragment of A8
on the background of 57, did not cause spongiosis,
confirming our previous report. Chimera R7a, which
contains the ClaI–AatII fragment of A8 on the background
of Rec5, caused spongiform neurodegeneration in 100% of
Fig. 1. Structures of A8, 57, and derived chimeric viruses. The viral
genomes are represented in their non-permutated form, flanked at their ends
by the LTR sequence. In chimeric viral genomes, solid regions are sequence-
derived from the A8 virus and open regions are sequence-derived from
57 viruses.
S. Takase-Yoden, R. Watanabe / Virology 336 (2005) 1–10 5infected rats. The lesion intensity of R7a-infected rats was
lower by 2 points compared to A8-infected rats (Table 1, P b
0.01). After replacement of the A8 enhancer region of R7a
with the 57-enhancer region, resulting in chimera R7c,
spongiosis was still induced in 100% of infected rats. The
lesion intensity of R7c-infected rats was lower by 2 points
compared to R7a-infected rats (P b 0.01). However, R5a,
which has an A8 enhancer region on a background of Rec5,
did not induce spongiosis. R7g, which contains the ClaI–
KpnI fragment of A8 on the background of Rec5, did not or
rarely induced spongiosis, but R7e, which contains the
KpnI–HindIII fragment of A8 on the background of Rec5,
caused spongiform neurodegeneration in 100% of infected
rats. Chimera R7f, which contains the KpnI–AatII fragment
of A8 on the background of Rec5, caused spongiform
neurodegeneration in 100% of infected rats, however, the
lesion intensity of R7f-infected rats was lower than that of
A8-infected rats (P b 0.001) and R7a-infected rats (P b
0.05), but was comparable with the lesion intensity of R7c-
and R7e-infected rats (P N 0.5) (Table 1). Chimera R7b,
which contains the AatII–HindIII fragment of A8 on the
background of Rec5, induced spongiosis in 25% of infected
rats; however, the lesion intensity was very low compared
with R7a-infected rats (P b 0.001). A8-virus infection and
R7a-virus infection caused hind-leg paralysis or weakness in
7 of 10 rats and 2 of 15 rats, respectively (Table 1). No rats
infected with other viruses exhibited clinical disease.Virus titers in the brains of rats infected with
neuropathogenic and non-neuropathogenic viruses
To investigate the correlation between neuropathogenic-
ity and virus titers in the brain of rats infected with chimeric
viruses containing neuropathogenic A8-Env, we measured
virus titers in the brain of rats infected with neuropathogenic
and non-neuropathogenic viruses. The virus titer in the
brains of rats infected with R7c was lower by two orders of
magnitude compared to rats infected with R7a (P b 0.001),
whereas R7c was still able to induced spongiform neuro-
degeneration (Table 1). The virus titers in the brains of rats
infected with R7c were similar to those infected by no- or
low-neuropathogenic viruses, R7g, R7b, R5a, Rec5, and 57
(P N 0.1). The virus titer in the brains of rats infected with
neuropathogenic R7f were comparable to those of rats
infected with low-neuropathogenic R7b and neuropatho-
genic R7e (P N 0.1). In the spleen, virus titers were similar
among R7a, R7c, R7g, R7e, R7f, R5a, and Rec5 (Table 1).
The titers in the spleen of rats infected with A8, R7b, and 57
were not determined.
Comparison of the expression of viral proteins, viral DNA
and viral transcripts in cultured cells infected with R7f and
Rec5
The neuro-pathogenicity of Rec5 was dramatically
altered when the 0.3 kb KpnI–AatII fragment was replaced
with that from A8, resulting in R7f, as shown in Table 1. In
order to examine the effects of the A8 0.3-kb KpnI–AatII
fragment on viral replication, we compared the amount of
viral DNA, viral transcripts and the viral proteins in R7f-
and Rec5-infected cultured cells.
The relative amount of viral DNA in F10 cells infected
with Rec5 and R7f was determined by PCR using primers
specific for the gag gene. The intensity of the gag
amplification product in R7f-infected F10 cells was
identical to that in Rec5-infected F10 cells (Fig. 2). The
intensity ratio of the band in R7f- and Rec5-infected F10
cells after normalization to the intensity of the band of h-
globin gene was 0.9. In independent experiments, the same
ratio was obtained (data not shown).
The relative amount of transcripts of proviral DNA in
F10 cells infected with Rec5 and R7f was determined by
RT-PCR. The full-length transcripts were detected by a
primer pair that amplifies a 236-bp fragment spanning the
3V end of the pol gene to the 5V end of the env gene
(Fig. 3A). The intensity ratio of the band of the full-length
transcripts in R7f- and Rec5-infected F10 cells after
normalization to the intensity of the band of 18S ribosomal
RNA was 1.2 (Fig. 3B). A second independent experiment
was performed, and the ratio was 1.1. The spliced
transcripts were detected by a primer pair that amplifies
a 254-bp fragment from the 3V end of LTR to the 5V end of
the env gene (Fig. 3A). The intensity ratio of the band of
the spliced transcripts in R7f- and Rec5-infected F10 cells
Fig. 2. Quantitative analysis of viral DNA in rat glial cells (F10) infected
with R7f and Rec5. Genomic DNA of cells was amplified PCR using
primers to target the 427-bp fragment of the gag gene of MLV. As an
internal control, primers for the 240-bp fragment of the rat h-globin gene
were used. Aliquots of the PCR mixture were resolved by agarose gel
electrophoresis and visualized under an image analyzer after ethidium
bromide staining, and the intensity of the band was measured using an
image analyzer. Twenty-four and 26 cycles are included in the linear range
of PCR using ethidium-bromide staining (see text). The signals for gag
were corrected for variations in the h-globin signal. The ratio of the signals
of gag in the R7f- and Rec5-infected cells was 0.9. This figure is
representative. In the independent experiment, the ratio was 0.9.
S. Takase-Yoden, R. Watanabe / Virology 336 (2005) 1–106after normalization to the band intensity of 18S ribosomal
RNA was 1.2 in two independent experiments (Fig. 3B). In
addition, viral reverse transcriptase activities of the cultureFig. 3. Quantitative analysis of the transcripts of viral genes in rat glial cells (F10) i
RT-PCR using random primers. The cDNA obtained was analyzed by PCR with
internal control for normalization of the signals of viral transcripts, primers to t
ethidium-bromide staining was determined (see text), and the signals of the transc
full-length viral transcripts in the R7f- and Rec5-infected cells was 1.2. The ratio
was 1.2. This figure is representative. In independent experiments, the ratio wassupernatant of R7f- and Rec5-infected F10 cells were
equivalent (data not shown).
Viral envelope protein is synthesized as a precursor
polyprotein (gpr85) consisting of N-terminal SU glycopro-
tein (gp70) and C-terminal transmembrane protein (TM).
Proteins gpr85 and gp70 were detected by Western blotting
using anti-Env antibody in cultured glial cells F10 infected
with A8 (Fig. 4A). Protein gp70 was mainly observed in F10
cells infected with Rec5 and R7f. Protein gpr85 was also
detected in these cells by long exposure. The intensity of the
gp70 band in R7f-infected F10 cells was 3-fold higher than
in Rec5-infected F10 cells. Gag precursor protein (p65Gag)
and p30Gag was detected by Western blotting using anti-
p30Gag antibody (Fig. 4B). In F10 cells infected with Rec5
and R7f, the expression of Gag precursor protein (p65Gag)
and p30Gag was similar. Two independent experiments were
performed and similar results were obtained.
Env expression in the brains of rats infected with
neuropathogenic and non-neuropathogenic viruses
To examine the expression levels of Env protein in the
CNS of rats infected with neuropathogenic and non-
neuropathogenic viruses, the intensity of antigen expression
was scored either in blood vessels or in glial cells of thenfected with R7f and Rec5 by RT-PCR. Total RNA of cells was subjected to
primers to detect the full-length transcripts and spliced transcripts. As an
arget the 18S ribosomal RNA were used. The linear range of PCR using
ripts were corrected for variations in the signals. The ratio of the signals of
of the signals of spliced viral transcripts in the R7f- and Rec5-infected cells
1.1 and 1.2 in full-length and spliced transcripts, respectively.
Fig. 4. Expression of Env protein (A) and Gag protein (B) in rat glial cells
(F10) infected with R7f and Rec5. F10 cells infected with A8 virus were
used as a control for the expression of proteins. Lysates of the infected
cells were analyzed by immunoblotting with anti-Env (gp70) and anti-Gag
(p30) antibodies. After re-probing, the blot was subsequently stained
using an anti-h-actin antibody to control for loading differences. This
figure is representative. Two independent experiments were performed,
and similar results were obtained.
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cerebellar cortex, cerebellar white matter and dentate
nucleus, pons, grey matter and white matter of the spinal
cord. The sum of each score in the seven separate areas is
shown in Table 2. The level of expression of Env protein in
both blood vessel and glial cells of R7c-infected rats was
higher than that of Rec5-infected rats (P b 0.001), although
the virus titers in the brains of R7c- and Rec5-infected rats
were similar (Table 1). There was no difference between the
expression level of Env protein of Rec5-infected rats and that
of 57-infected rats (P N 0.1). The expression level of Env
protein in both blood vessel and glial cells of R7f-infected
rats was comparable to that of R7c- and A8-infected rats, but
was higher than that of Rec5-infected rats (blood vessel: P b
0.001, glial cell: P b 0.01) (Table 2).Discussion
We previously reported that the LTR and 5V leader
sequence of A8 is essential for the induction of spongiformneurodegeneration in addition to the env gene, a primary
determinant for neuropathogenicity (Takase-Yoden and
Watanabe, 1997). In order to identify the genetic determinant
within the ClaI–HindIII fragment of A8, we constructed
additional chimerae between A8 and non-neuropathogenic
57 and examined the pathogenicity of these viruses. Rec5
did not cause spongiosis, consistent with our previous report.
R7a caused spongiform neurodegeneration with lesions of
comparable intensity to A8-infected rats (Table 1). However,
R7b exhibited low neuropathogenicity compared with R7a,
indicating that the determinant for neuropathogenicity
excluding A8-env is located within the ClaI–AatII frag-
ment of A8. Compared with R7g, R7f caused spongiform
neurodegeneration but R7g induced little or no spongiosis.
These results indicated that the 0.3-kb KpnI–AatII frag-
ment containing 0.04-kb of R, U5, and the 5V half of the 5V
leader of A8 is essential for the induction of spongiform
neurodegeneration. There were 17 differences in the
nucleotide sequence of this fragment between A8 and 57
(Fig. 5).
We examined whether the titer of the virus in the brain
correlated with the induction of spongiosis. Initially, we
looked for the region of the A8 gene that determined viral
titers in the brain. Viral titers in the brains of rats infected
with R7a were reduced by two orders of magnitude in R7c-
infected rats due to replacement of the BlpI–HphI fragment
of A8-LTR containing the nuclear factor-binding regions,
FVa, FVa, FVa, with the BlpI–BsiEI fragment of 57-LTR
containing the nuclear factor-binding regions FVa, FVb2/
NF1, FVa (Fig. 1 and Table 1). This finding indicated that
the enhancer region of A8-LTR is important in determining
viral titers in the brain. The titer of R5a was comparable to
that of Rec5 and the titer of R7g was comparable to that of
Rec5 and 57. Furthermore, titers of R7e and R7f in the brain
were higher by one order of magnitude than that of Rec5.
Therefore, additional determinants of the viral titer in the
brain are located within the KpnI–AatII fragment of A8,
which contains the R-U5-5V leader region. The BlpI–HphI
fragment containing the nuclear factor-binding regions and
the KpnI–AatII fragment are also determinants of viral titer
in the thymus as previously reported (Takase-Yoden and
Watanabe, 2002, 2004). In contrast, titers in the spleen were
equivalent for all viruses tested (Table 1). Therefore, it is
possible that there are tissue-specific events, including
regulation by a tissue-specific enhancer, in viral replication
in the target tissues. Kai and Furuta (1984) reported that the
titers of several neuropathogenic and non-neuropathogenic
viruses derived from Fr-MLV in the spleen of rats were
equivalent but those in the brain were different. We then
focused on the correlation between neuropathogenicity and
viral titers in the brain. Although the titers in the brain of
R7c-infected rats were lower by two orders of magnitude
than the titers of R7a-infected rats (Table 1), both R7a and
R7c were neuropathogenic. The titers in the brains of R7c-
infected rats were comparable to those of rats infected with
non-neuropathogenic R7g, R7b, R5a, Rec5, and 57 (Table
Fig. 5. Alignment of the KpnI–AatII fragment of A8 (accession no.D88386) and 57 (accession no. X02794). Asterisks represent the sequence identity. polyA:
polyadenylation signal, PBS: primer binding site, SD: splice donor site, glyco-Gag start; the start codon of glycosylated-Gag protein.
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the titers of these viruses in the brain were lower by one or
two orders of magnitude than those of neuropathogenic A8
and R7a viruses. These findings indicate that the amount of
infectious virus in the brain does not determine whether
spongiform neurodegeneration is induced. Compared
among A8, R7a, and R7c in the histopathological scores,
a correlation between lesion intensity and viral titers in the
brain was found (Table 1). Furthermore, a correlation
between clinical disease and viral titers in the brain was
observed. Therefore, it is suggested that the amount of
infectious virus in the brain influences the development of
lesions and disease.
In our previous studies, it was revealed that viral
replication in F10 cells has well-correlated neuropathoge-
nicity (Takase-Yoden and Watanabe, 1997), and we there-
fore used F10 cells in our in vitro studies. There was a
higher expression of Env protein in F10 cells infected with
neuropathogenic R7f than in those infected with non-
neuropathogenic Rec5 (Fig. 4A). The accumulation of
uncleaved envelope precursor protein (gpr85) in NIH3T3
cells or the presence of Env protein accompanied with
differential processing of N-linked sugar in glial cells in
neuropathogenic MLVs has been reported (Lynch and
Sharpe, 2000; Lynch et al., 1994; Szurek et al., 1990a,
1990b). In this study, no abundance of gpr85 in R7f-infected
F10 cells was observed (Fig. 4A). The amount of viral DNA
in R7f-infected F10 cells was comparable to that in Rec5-
infected F10 cells (Fig. 2). The amount of spliced transcripts
of the virus, from which Env protein is translated, in R7f-
infected F10 cells, was comparable to that in Rec5-infected
F10 cells (Fig. 3B), whereas the level of Env expression in
R7f-infected F10 cells was higher than that in Rec5-infected
F10 cells (Fig. 4A). These findings suggest that the
difference in Env expression between R7f- and Rec5-
infected F10 cells arises in the post-transcriptional step by
the regulation of the 0.3-kb KpnI–AatII fragment containingthe R-U5-5V leader region. The mechanism of post-tran-
scriptional regulation by the region is not understood,
however it was reported that the 5V leader sequence of Rous
sarcoma virus affects the translational steps (Hensel et al.,
1989; Moustakas et al., 1993; Sonstegard and Hackett,
1996). Another possibility is that the R region, which
contains the polyadenylation signal, in the 3V end of spliced
mRNA may affect the stability of the mRNA or efficiency
of translation (Das et al., 1999). In fact, four nucleotides
differ between A8 and 57 near the polyadenylation site (Fig.
5). Unlike the expression of Env protein, the expression of
Gag protein in Rec5- and R7f-infected F10 cells was
comparable (Fig. 4B). The amount of full-length transcripts
of the virus in R7f-infected F10 cells was comparable to that
in Rec5-infected F10 cells (Fig. 3). The reason the R-U5-5V
leader region has different effects on Env expression and
Gag expression is not yet clear. The distance between the 5V
end and AUG codon differs between the mRNA for Env and
the mRNA for Gag, because the splicing donor site is
located in the middle of the 0.3-kb KpnI–AatII fragment
(Fig. 5). These differences in the structure of Gag mRNA
and Env mRNA may induce different effects of the R-U5-5V
leader region in post-transcriptional events.
As shown in Table 2, the expression level of Env in the
brains of rats infected with neuropathogenic R7c was higher
compared with that in the brains of rats infected with non-
neuropathogenic Rec5, although the titers of these viruses in
the brain were equivalent (Table 1). The viral titer in the
brains of rats infected with neuropathogenic R7f was lower
by two orders of magnitude than that in the brains of rats
infected with neuropathogenic A8, but the expression level
of Env was equivalent (Table 2). These findings indicated
that the expression level of Env protein in the brain
correlated with neuropathogenicity. Reasons for the dis-
crepancy between expression levels of Env protein and titers
of infectious virus are unknown. However, the capacity to
produce infectious viruses in the brain may be independent
S. Takase-Yoden, R. Watanabe / Virology 336 (2005) 1–10 9of Env protein expression in the cells, but become depend-
ent at later stages, including viral assembly, genome
packaging, and budding.Acknowledgments
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